Cardiac tamponade epidemiology and demographics
|
Cardiac tamponade Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cardiac tamponade epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Cardiac tamponade epidemiology and demographics |
|
Risk calculators and risk factors for Cardiac tamponade epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]
Overview
The cardiac tamponade is most often attributed to the rupture of an acute myocardial infarction or an intrapericardial rupture of a dissecting ascending aortic aneurysm. In developed countries malignancy is the leading cause of cardiac tamponade secondary to pericardial effusion.
Epidemiology and Demographics
Incidence
- The incidence of cardiac tamponade based on a giant sample size of about 216 million emergency admissions was about 115,638(0.05%)[1]
Case-fatality rate/Mortality rate
- Cardiac temponade mortality rate is significantly different due to its underlying cause.[2][1]
- Overall, hospitalized mortality rate is around 14.3% and sub groups with higher mortality are :
- Sepsis (odds ratio:3.17)
- Chest trauma (odds ratio:2.15)
- Metastatic cancer:(odds ratio:1.90)
- Acute kidney injury(odds ratio:1.91)
- Idiopathic pericarditis (odds ratio: 0.21, least cause of mortality)
s
Age
Race
- There is no racial predilection to cardiac tamponade.
Gender
- Cardiac tamponade affects men and women equally.
- There is no study suggesting a meaningful sex difference among diagnosed patients.
Approximate Health Care cost In US
- It needs around 12 days of hospitalization and a mean cost of $160,397.
References
- ↑ 1.0 1.1 1.2 "CARDIAC TAMPONADE INCIDENCE, DEMOGRAPHICS AND IN-HOSPITAL OUTCOMES: ANALYSIS OF THE NATIONAL INPATIENT SAMPLE DATABASE | JACC: Journal of the American College of Cardiology".
- ↑ Porte HL, Janecki-Delebecq TJ, Finzi L, Métois DG, Millaire A, Wurtz AJ (1999). "Pericardoscopy for primary management of pericardial effusion in cancer patients". Eur J Cardiothorac Surg. 16 (3): 287–91. PMID 10554845.
- ↑ Gornik HL, Gerhard-Herman M, Beckman JA (2005). "Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion". J Clin Oncol. 23 (22): 5211–6. doi:10.1200/JCO.2005.00.745. PMID 16051963.